Van Hulzen Asset Management, LLC Sarepta Therapeutics, Inc. Transaction History
Van Hulzen Asset Management, LLC
- $1.32 Billion
- Q4 2024
A detailed history of Van Hulzen Asset Management, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Van Hulzen Asset Management, LLC holds 100 shares of SRPT stock, worth $10,535. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100Holding current value
$10,535% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SRPT
# of Institutions
535Shares Held
87.4MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$1.09 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$957 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$916 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$456 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$429 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.23B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...